Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
- T49.2X5DBillable
Adverse effect of local astringents and local detergents, subsequent encounter
- T49.2X5SBillable
Adverse effect of local astringents and local detergents, sequela
- T49.2X6ABillable
Underdosing of local astringents and local detergents, initial encounter
- T49.2X6DBillable
Underdosing of local astringents and local detergents, subsequent encounter
- T49.2X6SBillable
Underdosing of local astringents and local detergents, sequela
- T49.3X5ABillable
Adverse effect of emollients, demulcents and protectants, initial encounter
- T49.3X5DBillable
Adverse effect of emollients, demulcents and protectants, subsequent encounter
- T49.3X5SBillable
Adverse effect of emollients, demulcents and protectants, sequela
- T49.3X6ABillable
Underdosing of emollients, demulcents and protectants, initial encounter
- T49.3X6DBillable
Underdosing of emollients, demulcents and protectants, subsequent encounter
- T49.3X6SBillable
Underdosing of emollients, demulcents and protectants, sequela
- T49.4X5ABillable
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
- T49.4X5DBillable
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
- T49.4X5SBillable
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
- T49.4X6ABillable
Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
- T49.4X6DBillable
Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
- T49.4X6SBillable
Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
- T49.5X5ABillable
Adverse effect of ophthalmological drugs and preparations, initial encounter
- T49.5X5DBillable
Adverse effect of ophthalmological drugs and preparations, subsequent encounter
- T49.5X5SBillable
Adverse effect of ophthalmological drugs and preparations, sequela
- T49.5X6ABillable
Underdosing of ophthalmological drugs and preparations, initial encounter
- T49.5X6DBillable
Underdosing of ophthalmological drugs and preparations, subsequent encounter
- T49.5X6SBillable
Underdosing of ophthalmological drugs and preparations, sequela
- T49.6X5ABillable
Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
- T49.6X5DBillable
Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
- T49.6X5SBillable
Adverse effect of otorhinolaryngological drugs and preparations, sequela
- T49.6X6ABillable
Underdosing of otorhinolaryngological drugs and preparations, initial encounter
- T49.6X6DBillable
Underdosing of otorhinolaryngological drugs and preparations, subsequent encounter
- T49.6X6SBillable
Underdosing of otorhinolaryngological drugs and preparations, sequela
- T49.7X5ABillable
Adverse effect of dental drugs, topically applied, initial encounter
- T49.7X5DBillable
Adverse effect of dental drugs, topically applied, subsequent encounter
- T49.7X5SBillable
Adverse effect of dental drugs, topically applied, sequela
- T49.7X6ABillable
Underdosing of dental drugs, topically applied, initial encounter
- T49.7X6DBillable
Underdosing of dental drugs, topically applied, subsequent encounter
- T49.7X6SBillable
Underdosing of dental drugs, topically applied, sequela
- T49.8X5ABillable
Adverse effect of other topical agents, initial encounter
- T49.8X5DBillable
Adverse effect of other topical agents, subsequent encounter
- T49.8X5SBillable
Adverse effect of other topical agents, sequela
- T49.8X6ABillable
Underdosing of other topical agents, initial encounter
- T49.8X6DBillable
Underdosing of other topical agents, subsequent encounter
- T49.8X6SBillable
Underdosing of other topical agents, sequela
- T49.95XABillable
Adverse effect of unspecified topical agent, initial encounter
- T49.95XDBillable
Adverse effect of unspecified topical agent, subsequent encounter
- T49.95XSBillable
Adverse effect of unspecified topical agent, sequela
- T49.96XABillable
Underdosing of unspecified topical agent, initial encounter
- T49.96XDBillable
Underdosing of unspecified topical agent, subsequent encounter
- T49.96XSBillable
Underdosing of unspecified topical agent, sequela
- T50.0X5ABillable
Adverse effect of mineralocorticoids and their antagonists, initial encounter
- T50.0X5DBillable
Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
- T50.0X5SBillable
Adverse effect of mineralocorticoids and their antagonists, sequela
- T50.0X6ABillable
Underdosing of mineralocorticoids and their antagonists, initial encounter
- T50.0X6DBillable
Underdosing of mineralocorticoids and their antagonists, subsequent encounter
- T50.0X6SBillable
Underdosing of mineralocorticoids and their antagonists, sequela
- T50.1X5ABillable
Adverse effect of loop [high-ceiling] diuretics, initial encounter
- T50.1X5DBillable
Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
- T50.1X5SBillable
Adverse effect of loop [high-ceiling] diuretics, sequela
- T50.1X6ABillable
Underdosing of loop [high-ceiling] diuretics, initial encounter
- T50.1X6DBillable
Underdosing of loop [high-ceiling] diuretics, subsequent encounter
- T50.1X6SBillable
Underdosing of loop [high-ceiling] diuretics, sequela
- T50.2X5ABillable
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
- T50.2X5DBillable
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
- T50.2X5SBillable
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
- T50.2X6ABillable
Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
- T50.2X6DBillable
Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
- T50.2X6SBillable
Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
- T50.3X5ABillable
Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
- T50.3X5DBillable
Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
- T50.3X5SBillable
Adverse effect of electrolytic, caloric and water-balance agents, sequela
- T50.3X6ABillable
Underdosing of electrolytic, caloric and water-balance agents, initial encounter
- T50.3X6DBillable
Underdosing of electrolytic, caloric and water-balance agents, subsequent encounter
- T50.3X6SBillable
Underdosing of electrolytic, caloric and water-balance agents, sequela
- T50.4X5ABillable
Adverse effect of drugs affecting uric acid metabolism, initial encounter
- T50.4X5DBillable
Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
- T50.4X5SBillable
Adverse effect of drugs affecting uric acid metabolism, sequela
- T50.4X6ABillable
Underdosing of drugs affecting uric acid metabolism, initial encounter
- T50.4X6DBillable
Underdosing of drugs affecting uric acid metabolism, subsequent encounter
- T50.4X6SBillable
Underdosing of drugs affecting uric acid metabolism, sequela
- T50.5X5ABillable
Adverse effect of appetite depressants, initial encounter
- T50.5X5DBillable
Adverse effect of appetite depressants, subsequent encounter
- T50.5X5SBillable
Adverse effect of appetite depressants, sequela
- T50.5X6ABillable
Underdosing of appetite depressants, initial encounter
- T50.5X6DBillable
Underdosing of appetite depressants, subsequent encounter
- T50.5X6SBillable
Underdosing of appetite depressants, sequela
- T50.6X5ABillable
Adverse effect of antidotes and chelating agents, initial encounter
- T50.6X5DBillable
Adverse effect of antidotes and chelating agents, subsequent encounter
- T50.6X5SBillable
Adverse effect of antidotes and chelating agents, sequela
- T50.6X6ABillable
Underdosing of antidotes and chelating agents, initial encounter
- T50.6X6DBillable
Underdosing of antidotes and chelating agents, subsequent encounter
- T50.6X6SBillable
Underdosing of antidotes and chelating agents, sequela
- T50.7X5ABillable
Adverse effect of analeptics and opioid receptor antagonists, initial encounter
- T50.7X5DBillable
Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
- T50.7X5SBillable
Adverse effect of analeptics and opioid receptor antagonists, sequela
- T50.7X6ABillable
Underdosing of analeptics and opioid receptor antagonists, initial encounter
- T50.7X6DBillable
Underdosing of analeptics and opioid receptor antagonists, subsequent encounter
- T50.7X6SBillable
Underdosing of analeptics and opioid receptor antagonists, sequela
- T50.8X5ABillable
Adverse effect of diagnostic agents, initial encounter
- T50.8X5DBillable
Adverse effect of diagnostic agents, subsequent encounter
- T50.8X5SBillable
Adverse effect of diagnostic agents, sequela
- T50.8X6ABillable
Underdosing of diagnostic agents, initial encounter
- T50.8X6DBillable
Underdosing of diagnostic agents, subsequent encounter
